|
Volumn 15, Issue 3, 2012, Pages 568-569
|
Extracorporeal life support in the acute management of tumour lysis syndrome
|
Author keywords
Acute myeloid leukaemia; Chemotherapy; Extracorporeal life support; Extracorporeal membrane oxygenation; Malignancy; Tumour lysis syndrome
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTARABINE;
DAUNORUBICIN;
ETOPOSIDE;
ACUTE GRANULOCYTIC LEUKEMIA;
ACUTE KIDNEY FAILURE;
ARTICLE;
BONE MARROW EXAMINATION;
CANCER CHEMOTHERAPY;
CASE REPORT;
CHILD;
CHILD HEALTH CARE;
CLINICAL FEATURE;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
EXTRACORPOREAL OXYGENATION;
HUMAN;
INDUCTION CHEMOTHERAPY;
LEUKOCYTE COUNT;
MALE;
MULTIPLE ORGAN FAILURE;
PERCUTANEOUS DRAINAGE;
PERICARDIAL EFFUSION;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
RESPIRATORY FAILURE;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
TREATMENT DURATION;
TUMOR LYSIS SYNDROME;
VASCULAR ACCESS;
ANTINEOPLASTIC AGENTS;
EXTRACORPOREAL MEMBRANE OXYGENATION;
HUMANS;
INFANT;
LEUKEMIA, MYELOID, ACUTE;
MALE;
TUMOR LYSIS SYNDROME;
|
EID: 84869404733
PISSN: 15699293
EISSN: 15699285
Source Type: Journal
DOI: 10.1093/icvts/ivs233 Document Type: Article |
Times cited : (9)
|
References (5)
|